Lipoprotein Apheresis-Reference-Cited by-同舟云学术

Lipoprotein Apheresis

Published:2016-03 Issue:1 Volume:45 Page:39-54
ISSN:0889-8529
Container-title:Endocrinology and Metabolism Clinics of North America
language:en
Short-container-title:Endocrinology and Metabolism Clinics of North America

Author:

Moriarty Patrick M.,Hemphill Linda

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference95 articles.

1. Homozygous cutaneo-tendinous forms of hypercholesteremic xanthomatosis in an exemplary familial case. Trial of plasmapheresis and heroic treatment;de Gennes;Bull Mem Soc Med Hop Paris,1967

2. Double filtration plasmapheresis;Agishi;Trans Am Soc Artif Intern Organs,1980

3. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia;Stoffel;Lancet,1981

4. Management of familial hypercholesterolemias in adult patients: recommendations from the national lipid association expert panel on familial hypercholesterolemia;Ito;J Clin Lipidol,2011

5. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy;Vishwanath;J Clin Lipidol,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potential of Lipoprotein(a) Inhibitors;Drugs;2024-06

2. Acute Increase in Ocular Microcirculation Blood Flow Upon Cholesterol Removal. The Eyes Are the Window of the Heart;The American Journal of Medicine;2023-01

3. Therapies for Lowering Low-Density Lipoprotein Cholesterol;Pediatric Dyslipidemia;2023

4. Lipoprotein(a) and Cardiovascular Disease in Chinese Population;JACC: Asia;2022-11

5. Targeting Lipoprotein (a) to Understand its Impact on Atherosclerotic Cardiovascular Disease;Current Pharmaceutical Design;2022-10